COVID-19 battlefield-ANKE’ s AI technology assist CT diagnosis



Until 23th of March, the COVID-19 had infected over 100 countries in the world, it almost covered every continent in the earth, and spread very rapily over the world. The total existing confirmed coronavirus cases already close to 220000 and the accumulated cases had already over 250000. Some countries such as Italy, Iran, Germany, France, and Spain are all severely frustrated. On the date fo 11st of March the World Health Organization had announced the COVID-19 breakout as a pandemic (is a disease epidemic that has spread across a large region, for instance multiple continents, or worldwide). Currently, the world are shrouded in the fight against COVID-19 atmosphere. This is really an intense challenge for all the medical related workers. How to use the latest technology to achieve the best testing and diagnosis results had become the most urgent and concerned subject.


Nowadyas, the AI technology as the latest cutting-edge high-tech science and technology, it has been used for many manufacture industries to optimize the products’ performance. In recent years, the AI technology had been wildely used for the CT technology in medical imaging field, including ANKE. In this article, we will show you how does the ANKE’s AI technology assit the CT analysis.

The reliability of CT diagnosis for COVID-19


According to some medical imaging clinical research, the early diagnosis of COVID-19 is really essential for the COVID treatment, and it is also a very crucial action to control the spread of the disease. To compared with RT-PCR, lung CT  imaging is more reliable, practical, also a fast method for diagnosing and evaluating COVID-19, especially in endemic areas. On 26th of February in 2020, Oakbrook in Illinois had pubulished a research in Radiology. This acedemic journal was based on  a 1000 patient clinical research, and it indicates about 81% of patients with negative RT-PCR results but positive chest CT scans were reclassified as high-probability or probable cases of COVID-19 through the detailed clinical symptoms and comprehensive analysis or track of typical CT manifestations.

Moreover, another study found that the sensitivity of CT to COVID-19 infection was 98%, while the sensitivity of RT-PCR was 71%. Therefore, CT is currently considered as the main screening tool for COVID-19.

ANKE’ s  AI technology assisted CT analysis to conquer COVID-19


During this breaking event, China, as the clustering place of the COIVD-19 cases, and the central countries to fight the epidemic, we have the inescapable duty to promote our most effective medical treatment experiences to worldwide.


Through over two months efforts, except the CT donation, shelter CT solution and mobile CT solution,  ANKE’s R&D team also developed an artificial intelligence-based CT to assist detection system for coronavirus cases, which played a huge role in the COVID-19 battlefield.

A short-time AI imaging analysis technology - 30 seconds to automatically determine the location of pneumonia, providing the accurate and effective results for doctors.

In 2019, ANKE's R&D team has launched AI workstations on the market. Its functions include AI automatic diagnosis of pulmonary nodules, emphysema, and cerebral hemorrhage. In December 2019, after the alarm of China's Coronavirus breakout, ANKE began working overtime from the second day of the new year to invest in CT production to support the epidemic-stricken areas. Later, it designed a square cabin CT to support mobile medical treatment. Now, after 3 months of hard work, we have the "Automatic Pneumonia AI Detection" again to assist doctors in CT diagnosis of Covid-19 patients.


In ANKE’s AI technology, we use the recorded big data to learn and analyze the typical features and locations of these CT images through “deep learning” methodology. The system can read and analyze a patient's CT scan within 30 seconds. At present, it has been put into ANKE’s AI workstation, together with other AI analysis functions. As more and more scans are completed, our algorithm will learn with the virus and improve accuracy. The value of artificial intelligence works by reducing the burden on clinicians in the current COVID-19 epidemic and other situations.